These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15834287)

  • 1. Role of nitric oxide in modulating systemic pressor responses to different vasoconstrictors in man.
    van der Linde NA; Boomsma F; van den Meiracker AH
    J Hypertens; 2005 May; 23(5):1009-15. PubMed ID: 15834287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pressor and mesenteric arterial hyporesponsiveness to angiotensin II is an early event in haemorrhagic hypotension in anaesthetised rats.
    Pieber D; Horina G; Sandner-Kiesling A; Pieber TR; Heinemann A
    Cardiovasc Res; 1999 Oct; 44(1):166-75. PubMed ID: 10615400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide regulation of TP receptor-mediated pulmonary vasoconstriction in the anesthetized, open-chest rat.
    Valentin JP; Bessac AM; Maffre M; John GW
    Eur J Pharmacol; 1996 Dec; 317(2-3):335-42. PubMed ID: 8997619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute intravenous injection and short-term oral administration of N(G) -nitro-L-arginine methyl ester to the rat provoke increased pressor responses to agonists and hypertension, but not inhibition of acetylcholine-induced hypotensive responses.
    López RM; Pérez T; Castillo C; Castillo MC; Castillo EF
    Fundam Clin Pharmacol; 2011 Jun; 25(3):333-42. PubMed ID: 20608990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-II-induced increase in transcoronary protein clearance: role of hypertension vs. nitric oxide or cyclo-oxygenase products.
    Sigusch HH; Ou R; Katwa LC; Campbell SE; Ganjam VK; Reddy HK; Weber KT
    Cardiovasc Res; 1995 Aug; 30(2):291-8. PubMed ID: 7585817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous nitric oxide and epoxyeicosatrienoic acids modulate angiotensin II-induced constriction in the rabbit afferent arteriole.
    Kohagura K; Endo Y; Ito O; Arima S; Omata K; Ito S
    Acta Physiol Scand; 2000 Jan; 168(1):107-12. PubMed ID: 10691787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender difference in vascular and platelet reactivity to thromboxane A(2)-mimetic U46619 and to endothelial dependent vasodilation in Zucker fatty (hypertensive, hyperinsulinemic) diabetic rats.
    Ajayi AA; Hercule H; Cory J; Hayes BE; Oyekan AO
    Diabetes Res Clin Pract; 2003 Jan; 59(1):11-24. PubMed ID: 12482637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide scavenging by hydroxocobalamin may account for its hemodynamic profile.
    Gerth K; Ehring T; Braendle M; Schelling P
    Clin Toxicol (Phila); 2006; 44 Suppl 1():29-36. PubMed ID: 16990191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide participates in the renal vasodilatory effect of candesartan in anesthetized rats.
    Demeilliers B; Mimran A; Jover B
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S208-12. PubMed ID: 9892165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in angiotensin II metabolism contribute to the increased pressor response to angiotensin after chronic treatment with L-NAME in the spontaneously hypertensive rat.
    Yang Y; Macdonald GJ; Duggan KA
    Clin Exp Pharmacol Physiol; 1996; 23(6-7):611-3. PubMed ID: 8800601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury.
    Pojoga LH; Yao TM; Opsasnick LA; Siddiqui WT; Reslan OM; Adler GK; Williams GH; Khalil RA
    J Pharmacol Exp Ther; 2015 Oct; 355(1):32-47. PubMed ID: 26183312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
    Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF
    Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of nitric oxide and the renin angiotensin system in renal hypertensive rats.
    Lee BH; Shin HS
    Jpn J Pharmacol; 1997 May; 74(1):83-90. PubMed ID: 9195301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
    Clayton JS; Clark KL; Johns EJ; Drew GM
    Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of nitric oxide in the cerebrovascular response to hypercapnia.
    Smith JJ; Lee JG; Hudetz AG; Hillard CJ; Bosnjak ZJ; Kampine JP
    Anesth Analg; 1997 Feb; 84(2):363-9. PubMed ID: 9024030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute exercise enhances nitric oxide modulation of vascular response to phenylephrine.
    Patil RD; DiCarlo SE; Collins HL
    Am J Physiol; 1993 Oct; 265(4 Pt 2):H1184-8. PubMed ID: 8238404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of nitric oxide in the development of vascular alpha 1-adrenoreceptor desensitization and pressure diuresis in conscious rats.
    Minami N; Imai Y; Nishiyama H; Abe K
    Hypertension; 1997 Apr; 29(4):969-75. PubMed ID: 9095085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of angiotensin II in L-NAME-induced systemic and renal hemodynamic effects in hydrochlorothiazide-pretreated hypertensive subjects.
    van der Linde NA; van den Meiracker AH; Boomsma F
    J Hypertens; 2003 Feb; 21(2):345-51. PubMed ID: 12569265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of L-NAME-induced systemic and renal vasoconstrictor responses by alpha1-adrenoceptor antagonism.
    van der Linde NA; Boomsma F; van den Meiracker AH
    J Hypertens; 2005 May; 23(5):1017-24. PubMed ID: 15834288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of nitric oxide after acute hypertension.
    Nava E; Rodríguez F; Moreno C; Llinás MT; Salazar FJ
    J Cardiovasc Pharmacol; 2000 Oct; 36(4):444-50. PubMed ID: 11026644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.